4.7 Article

The Year in Acute Coronary Syndrome

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 63, Issue 3, Pages 201-214

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2013.10.041

Keywords

biomarkers; coronary stent(s); myocardial infarction; plaque rupture; platelets; thrombosis; troponin

Funding

  1. Amgen
  2. Daiichi-Sankyo
  3. Merck
  4. AstraZeneca
  5. Johnson Johnson
  6. Beckman Coulter
  7. Roche Diagnostics
  8. Sanofi-Aventis
  9. GlaxoSmithKline
  10. Bristol-Myers Squibb

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available